CUE BIOPHARMA
Cue Biopharma (Cue) is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. Cue biologics generate tailored immune responses in disease-relevant T cell populations by emulating the signals, or cues, delivered by the body’s antigen-presenting cells (APCs), and can potentially address any T cell-mediated disease. Through this platform approach, Cue has developed a portfolio of promising drug ... candidates with two lead programs currently approaching the clinic. Headquartered in Kendall Square, Cambridge, Massachusetts, Cue is led by a strong, experienced management team and scientific advisory board (SAB) with deep expertise in the design and clinical development of protein biologics, immunology, and immuno-oncology.
CUE BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cuebiopharma.com
Total Employee:
11+
Status:
Active
Contact:
617-949-2680
Total Funding:
26.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Nginx
Similar Organizations
ALung Technologies
ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
BioMarck Pharmaceuticals
BioMarck Pharmaceuticals develops new drugs for the treatment of pulmonary diseases.
CN Bio Innovations
CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Fuse Medical
Fuse Medical distributes healthcare products and supplies to ambulatory surgical centers and hospitals.
Kypha
Kypha develops technology and clinical products to improve monitoring and treatment of autoimmune and inflammatory diseases.
NanoBio Designs
NanoBio Designs offers an efficient detection platform to verify the presence or absence and levels of targeted genetic markers in samples.
Sextant Therapeutics
Sextant is developing personalized cancer therapies that trigger the tumor to recruit the patient's own cancer-killing immune response.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Stereotaxis
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.
Theravectys
Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MDB Capital Group
MDB Capital Group investment in Series B - Cue Biopharma
MDB Capital Group
MDB Capital Group investment in Series A - Cue Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-15 | Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer |
Official Site Inspections
http://www.cuebiopharma.com Semrush global rank: 4.72 M Semrush visits lastest month: 2.01 K
- Host name: 157.167.196.104.bc.googleusercontent.com
- IP address: 104.196.167.157
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
